154 related articles for article (PubMed ID: 29507861)
1. Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.
Maatman BT; Schmeisser G; Kreutz RP
J Diabetes Res; 2018; 2018():4543065. PubMed ID: 29507861
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Kreutz RP; Owens J; Breall JA; Lu D; von der Lohe E; Bolad I; Sinha A; Flockhart DA
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):321-6. PubMed ID: 23429252
[TBL] [Abstract][Full Text] [Related]
3. Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes.
Lu D; Owens J; Kreutz RP
Thromb Res; 2013 Aug; 132(2):e94-8. PubMed ID: 23920429
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis.
Kornblith LZ; Kutcher ME; Redick BJ; Calfee CS; Vilardi RF; Cohen MJ
J Trauma Acute Care Surg; 2014 Feb; 76(2):255-6; discussion 262-3. PubMed ID: 24458031
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity.
Kreutz RP; Schmeisser G; Schaffter A; Kanuri S; Owens J; Maatman B; Sinha A; von der Lohe E; Breall JA
TH Open; 2018 Apr; 2(2):e173-e181. PubMed ID: 30882064
[TBL] [Abstract][Full Text] [Related]
6. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Ambrose JA
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):75-9. PubMed ID: 19815816
[TBL] [Abstract][Full Text] [Related]
7. Thromboelastography with Platelet Mapping Identifies High Platelet Reactivity is Associated with Obesity, Diabetes, and Thrombotic Events.
Hall R; Suarez S; Majumdar M; Lee I; Zacharias N; Gee D; Dua A
Ann Vasc Surg; 2024 Jul; 104():227-236. PubMed ID: 38490537
[TBL] [Abstract][Full Text] [Related]
8. Clot Formation Is Associated With Fibrinogen and Platelet Forces in a Cohort of Severely Injured Emergency Department Trauma Patients.
White NJ; Newton JC; Martin EJ; Mohammed BM; Contaifer D; Bostic JL; Brophy GM; Spiess BD; Pusateri AE; Ward KR; Brophy DF
Shock; 2015 Aug; 44 Suppl 1(0 1):39-44. PubMed ID: 25643013
[TBL] [Abstract][Full Text] [Related]
9. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
10. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.
Harr JN; Moore EE; Ghasabyan A; Chin TL; Sauaia A; Banerjee A; Silliman CC
Shock; 2013 Jan; 39(1):45-9. PubMed ID: 23247121
[TBL] [Abstract][Full Text] [Related]
11. Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke.
Yao X; Dong Q; Song Y; Wang Y; Deng Y; Li Y
Cerebrovasc Dis; 2014; 38(3):182-90. PubMed ID: 25300785
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of different functional fibrinogen polymerization assays in eliminating platelet contribution to clot strength in thromboelastometry.
Schlimp CJ; Solomon C; Ranucci M; Hochleitner G; Redl H; Schöchl H
Anesth Analg; 2014 Feb; 118(2):269-276. PubMed ID: 24445628
[TBL] [Abstract][Full Text] [Related]
13. Systemic central venous oxygen saturation is associated with clot strength during traumatic hemorrhagic shock: A preclinical observational model.
White NJ; Martin EJ; Shin Y; Brophy DF; Diegelmann RF; Ward KR
Scand J Trauma Resusc Emerg Med; 2010 Dec; 18():64. PubMed ID: 21138566
[TBL] [Abstract][Full Text] [Related]
14. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
15. Effects of direct oral anticoagulants on thromboelastographic parameters and fibrin clot properties in patients with venous thromboembolism.
Kopytek M; Zabczyk M; Natorska J; Malinowski KP; Undas A
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32350148
[TBL] [Abstract][Full Text] [Related]
16. Electron microscopic evaluations of clot morphology during thrombelastography.
Kawasaki J; Katori N; Kodaka M; Miyao H; Tanaka KA
Anesth Analg; 2004 Nov; 99(5):1440-1444. PubMed ID: 15502045
[TBL] [Abstract][Full Text] [Related]
17. Interaction Between Platelet and Fibrinogen on Clot Strength in Healthy Patients.
Maslow A; Cheves T; Joyce MF; Apruzzese P; Sweeney J
J Cardiothorac Vasc Anesth; 2023 Jun; 37(6):942-947. PubMed ID: 36933991
[TBL] [Abstract][Full Text] [Related]
18. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
[TBL] [Abstract][Full Text] [Related]
19. Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study.
Jenny L; Melmer A; Laimer M; Hardy ET; Lam WA; Schroeder V
Diab Vasc Dis Res; 2020; 17(1):1479164120903044. PubMed ID: 32037878
[TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
